1
Clinical Trials associated with FWY003A Randomized, Double Masked, Placebo-controlled, Multicenter, Dose-range Finding Study to Assess the Efficacy and Safety of FWY003 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
100 Clinical Results associated with FWY003
100 Translational Medicine associated with FWY003
100 Patents (Medical) associated with FWY003
100 Deals associated with FWY003